Abstract
Disseminated strongyloidiasis is often fatal, despite treatment with oral albendazole and parenteral ivermectin (IVM). Here, we report elevated plasma IVM and albendazole sulfoxide concentrations in the context of extra-corporeal membrane oxygenation and continuous renal replacement therapyinapatient with disseminated strongyloidiasis treated with subcutaneous IVM and nasogastric albenzadole. Despite elevated drug plasma concentrations, live filariform larvae were detected in endotracheal aspirates after 2 weeks of treatment.
Original language | English (US) |
---|---|
Pages (from-to) | 1194-1197 |
Number of pages | 4 |
Journal | American Journal of Tropical Medicine and Hygiene |
Volume | 99 |
Issue number | 5 |
DOIs | |
State | Published - 2018 |
ASJC Scopus subject areas
- Parasitology
- Virology
- Infectious Diseases